Baxter's Robert Parkinson - CEO Pay

Robert Parkinson, Baxter CEO

Baxter - Robert Parkinson

 

Total Compensation: $17.6M

 

2007 Revenue: $11.3B
2006 Revenue: $10.4B
Change: 8.6%

 

Details: Parkinson's $17.6 million haul was driven primarily by strong company and individual performance in 2007 and 2006. According to the company's proxy statement, Parkinson's compensation "reflects the role he has played in the turnaround of the company since his arrival in 2004." Parkinson gained $1.29M in base salary, $3.75M in stock option awards, and $2.28 in additional pension.

 

Baxter News:
Baxter: Fake heparin predated API
Baxter recalls heparin on adverse events

Baxter's Robert Parkinson - CEO Pay
Read more on

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.